Summary of this article
Amanta Healthcare IPO shares to list on September 9
GMP signals a positive listing for Amanta Healthcare shares
Based on the latest GMP, Amanta Healthcare’s shares is likely to list at Rs 135 apiece
Shares of Amata Healthcare are set to make their stock market debut on September 9, 2025, after share allotment was finalised on September 4.
The pharmaceutical company’s Rs 126-crore initial public offering (IPO) saw strong demand across investor categories, gathering bids 82.61 times the shares on offer. The qualified institutional buyers (QIBs) portion was subscribed 35.86 times, the non-institutional investors (NIIs) segment saw subscription rocketing up to 209.42 times, while the retail investor quota received bids 54.98 times the shares on offer.
Investors had a three-day window, from September 1 to 3, to bid for the IPO, which was offered at the upper band price of Rs 126 per share.
Amanta Healthcare IPO GMP, Expected Listing Price
Unlisted market trends hint at a positive debut for Amanta Healthcare, as several market watchers tracking the grey market premium (GMP) suggest that its shares are quoting a GMP of Rs 9 over the issue price of Rs 126.
The GMP signals that the stock could list at Rs 135 per share, a premium of 7.14 per cent over the issue price.
Amanta Healthcare IPO Details
The Amanta Healthcare IPO's book running lead manager is Beeline Capital Advisors, and the registrar of the issue is MUFG Intime India.
The issue is entirely a fresh issue of 10 million shares. 50 per cent of these shares were reserved for QIBs, 15 per cent for NIIs and 35 per cent for retail investors.
Ahead of the subscription, Amanta Healthcare raised Rs 37.80 crore from anchor investors.
Amanta Healthcare is a pharmaceutical company that develops, manufactures and markets sterile liquid products. Its portfolio includes parenterals packed in plastic containers using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. The company produces both large and small volume parenterals across six therapeutic segments.
Amanta Healthcare plans to use the net proceeds from the IPO to expand its Hariyala facility in Kheda, Gujarat.
Amanta Healthcare Financial Performance
Amanta Healthcare’s revenue came in at Rs 276.09 crore in FY25, slightly lower than Rs 281.60 crore in FY24, but above Rs 262.69 crore reported in FY23. Its earnings before interests, taxes, depreciation, and amortisation (Ebitda) rose to Rs 61.05 crore in FY25, as against Rs 58.75 crore in FY24 and Rs 56.30 crore in FY23.
The company’s profit after tax (PAT) climbed to Rs 10.50 crore in FY25, from Rs 3.63 crore in FY24, while it had posted a loss of Rs 2.11 crore in FY23.
